C.R. Bard to Acquire Rochester Medical for $262 Million (BCR, ROCM)

C.R. Bard to Acquire Rochester Medical for $262 Million (BCR, ROCM)

RSS

C.R. Bard, Inc. (BCR) announced on Wednesday that it will acquire urine drainage care product company, Rochester Medical Corporation (ROCM).

BCR will purchase ROCM for about $262 million, or $20 per share. This acquisition will help BCR expand its urology homecare market. The deal is expected to close later this year.

C.R. Bard shares were mostly flat during pre-market trading Wednesday. The stock is up 17% YTD.

Rochester Medical shares were up $6.04, or 43.74%, during pre-market trading Wednesday. The stock is up 37% YTD.

The Bottom Line

Shares of C.R. Bard, Inc. (BCR) have a 0.73% yield, based on Tuesday’s closing price of $114.66.

C.R. Bard, Inc. (BCR) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today